• Lifshitz Law Firm, P.C. Announces Investigation of AEGN, COHR, KSHB, GNLN, KSU, CP, LEAF, MLND, MSGN, MSGE, and TPCO

    Aegion Corporation (NASDAQ: AEGN) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of AEGN to affiliates of New Mountain Capital, L.L.C. for $26.00 per share. If you are a investor, and... Read more

  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Scholar Rock Holding Corporation - SRRK

    Pomerantz LLP is investigating claims on behalf of investors of Scholar Rock Holding Corporation ("Scholar Rock" or the "Company") (NASDAQ: SRRK). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.... Read more

  • Planting People Growing Justice Honored in Social Enterprise Impact Showcase for Social Change

    ST. PAUL, Minn. - -- Planting People Growing Justice (PPGJ) has been named a 2020 honoree in the Social Enterprise Impact Showcase. The organization founded by Dr. Artika Tyner is being celebrated for its bookstore and publishing house, Planting People.... Read more

  • Saturday WrestleMania® Sold Out

    A sell-out of 25,675 fans attended Night One of WrestleMania at Raymond James Stadium in Tampa Bay, FL with millions more watching at home on Peacock in the U.S. and on WWE Network around the world. Adhering to local health guidelines, a limited number.... Read more

  • International Buzz Around Vancouver Media Company's Online Art Collection

    Over the first 48 since launch, the site has seen over 1800 visitors from Russia, Germany, Ukraine, Romania and other overseas locations in addition to visitors from Beverly Hills, New York, Washington, Cambridge, Ann Arbor and Houston.. Read more

  • 10266201

    More Than 100 Business Leaders Join Call To Discuss Non-Partisan Action Against Restrictive Voting Law Proposals

    CEOs strongly indicate they will re-evaluate donations to candidates supporting restrictions on voter access in a live poll. Read more

  • YFX.COM - Protocols and Products That Serve Users

    YFX.COM is the world's first decentralized cross-chain perpetual contract exchange. While other trading platforms that provide leverage alternatives exist, YFX.COM is trailblazing a decentralized alternative to centralized exchanges and perpetual.... Read more

  • Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer

    Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today.... Read more

  • Brandon Dawson Raises $250,000 For The Grant Cardone Foundation

    Brandon Dawson, CEO and co-founder of Cardone Ventures, raised $50,000 for the Grant Cardone Foundation and matched it with a $200,000 donation.. Read more

  • EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Champignon Brands Inc. Investors – SHRMF

    Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Champignon Brands Inc. (OTC: SHRMF) between March 27, 2020 and February 17, 2021, inclusive (the "Class.... Read more

  • AHF Welcomes Biden's Proposed 15% HUD Budget Increase

    COVID's devastating impact on housing and homeless services programs nationwide has stretched state and local budgets and responses from coast to coast. Read more

  • Positive Findings From Phase 1b Trial of GlycoMimetics' GMI-1359 To Be Presented at AACR 2021 Meeting

    Preclinical research included in poster supports clinical findings and demonstrates enhanced immune response in metastatic breast carcinoma model. Read more

  • Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's Lymphoma

    Results from the randomized, double-blind, placebo-controlled Phase III trial CHRONOS-3 show a significant improvement in progression-free survival (PFS) with the investigational combination of Aliqopa® (copanlisib) and rituximab given intravenously in.... Read more

  • Sysmex Inostics Presents Data at AACR Demonstrating SafeSEQ NGS Liquid Biopsy Delivers Equivalent Performance to the Extensively Clinically Validated OncoBEAM dPCR Technology for NSCLC Patients

    Sysmex Inostics, Inc., a global leader of the liquid biopsy revolution for oncology, is presenting the poster "Clinical evaluation of NGS-based liquid biopsy testing in non-small cell lung cancer (NSCLC) patients" at the 112th Annual Meeting of the.... Read more

  • ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting

    ESSA Pharma Inc. ("ESSA" or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today presented new preclinical data on ESSA's lead product candidate, EPI.... Read more

  • Sumitomo Dainippon Pharma Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

    Sumitomo Dainippon Pharma Oncology, Inc., a clinical-stage company focused on research and development for novel cancer therapeutics, today presented new findings on a range of investigational agents from the company's pipeline at the American.... Read more

  • OncoMyx Presents at AACR First Data Showing Multi-Armed Myxoma Virotherapy Can Modulate Anti-Tumor Immune Response

    OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company, today announced the presentation of three posters at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, taking place April 10-15, 2021. The data are the.... Read more

  • SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors

    SQZ enhanced APCs (eAPCs) demonstrated ability to meaningfully increase CD8 T cell response through incorporation of costimulatory molecules and cytokine signaling. Read more

  • Tachyon Presents Promising Preclinical Data on Its First-in-class Pan-KDM4 Epigenetic Regulator, TACH101

    Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a research and development biotechnology company, today announced a presentation of data of the Company's novel compound, TACH101, at the American Association for Cancer Research ("AACR") Annual.... Read more

  • Tallac Therapeutics Presents New Data on Toll-like Receptor Agonist Antibody Conjugate, TAC-001, at the 2021 Virtual Annual Meeting of the American Association for Cancer Research (AACR)

    TAC-001, Tallac's lead candidate from novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) platform, induces innate and adaptive immune responses that generate potent anti-tumor activity in preclinical study. Read more

  • Pomerantz Law Firm Announces the Filing of a Class Action against Canoo Inc., and Certain Officers - GOEV; GOEVW; HCAC; HCACW

    Pomerantz LLP announces that a class action lawsuit has been filed against Canoo, Inc. (formerly known as Hennessy Capital Acquisition Corp. IV) ("Canoo" or the "Company") (NASDAQ: GOEV; GOEVW; HCAC; HCACW) and certain of its officers. The class action.... Read more